Huntington disease
Huntington disease is devastating to patients and their families—with autosomal dominant
inheritance, onset typically in the prime of adult life, progressive course, and a combination …
inheritance, onset typically in the prime of adult life, progressive course, and a combination …
Huntington disease: natural history, biomarkers and prospects for therapeutics
CA Ross, EH Aylward, EJ Wild, DR Langbehn… - Nature Reviews …, 2014 - nature.com
Huntington disease (HD) can be seen as a model neurodegenerative disorder, in that it is
caused by a single genetic mutation and is amenable to predictive genetic testing, with …
caused by a single genetic mutation and is amenable to predictive genetic testing, with …
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg… - JAMA …, 2019 - jamanetwork.com
Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a
number of neurological conditions compared with healthy controls (HC) and is a candidate …
number of neurological conditions compared with healthy controls (HC) and is a candidate …
Multisurface proximal support vector machine classification via generalized eigenvalues
OL Mangasarian, EW Wild - IEEE transactions on pattern …, 2005 - ieeexplore.ieee.org
A new approach to support vector machine (SVM) classification is proposed wherein each of
two data sets are proximal to one of two distinct planes that are not parallel to each other …
two data sets are proximal to one of two distinct planes that are not parallel to each other …
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by both
neurological and systemic abnormalities. We examined the peripheral immune system and …
neurological and systemic abnormalities. We examined the peripheral immune system and …
[HTML][HTML] Targeting huntingtin expression in patients with Huntington's disease
SJ Tabrizi, BR Leavitt… - … England Journal of …, 2019 - Mass Medical Soc
Background Huntington's disease is an autosomal-dominant neurodegenerative disease
caused by CAG trinucleotide repeat expansion in HTT, resulting in a mutant huntingtin …
caused by CAG trinucleotide repeat expansion in HTT, resulting in a mutant huntingtin …
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Huntington disease (HD) is a neurodegenerative disease caused by CAG repeat expansion
in the huntingtin gene (HTT) and involves a complex web of pathogenic mechanisms …
in the huntingtin gene (HTT) and involves a complex web of pathogenic mechanisms …
[HTML][HTML] Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Background Blood biomarkers of neuronal damage could facilitate clinical management of
and therapeutic development for Huntington's disease. We investigated whether …
and therapeutic development for Huntington's disease. We investigated whether …
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
SJ Tabrizi, C Estevez-Fraga… - The Lancet …, 2022 - thelancet.com
Huntington's disease is the most frequent autosomal dominant neurodegenerative disorder;
however, no disease-modifying interventions are available for patients with this disease. The …
however, no disease-modifying interventions are available for patients with this disease. The …
Therapies targeting DNA and RNA in Huntington's disease
EJ Wild, SJ Tabrizi - The Lancet Neurology, 2017 - thelancet.com
No disease-slowing treatment exists for Huntington's disease, but its monogenic inheritance
makes it an appealing candidate for the development of therapies targeting processes close …
makes it an appealing candidate for the development of therapies targeting processes close …